Eli Lilly to provide Migraine drug Reyvow Farhat Nasim4 Feb 2020 9:00 AM ISTNew Delhi: Eli Lilly and Company announced recently that REYVOW (lasmiditan) C-V 50 mg and 100 mg tablets, an oral medication for the acute treatment...